CA2854271C - Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo - Google Patents

Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo Download PDF

Info

Publication number
CA2854271C
CA2854271C CA2854271A CA2854271A CA2854271C CA 2854271 C CA2854271 C CA 2854271C CA 2854271 A CA2854271 A CA 2854271A CA 2854271 A CA2854271 A CA 2854271A CA 2854271 C CA2854271 C CA 2854271C
Authority
CA
Canada
Prior art keywords
ngf
vitiligo
skin
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2854271A
Other languages
English (en)
French (fr)
Other versions
CA2854271A1 (en
Inventor
Silvana LIOTTA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOMED VENTURE Srl UNIPERSONALE Soc
Original Assignee
BIOMED VENTURE Srl UNIPERSONALE Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOMED VENTURE Srl UNIPERSONALE Soc filed Critical BIOMED VENTURE Srl UNIPERSONALE Soc
Publication of CA2854271A1 publication Critical patent/CA2854271A1/en
Application granted granted Critical
Publication of CA2854271C publication Critical patent/CA2854271C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2854271A 2011-11-02 2012-11-02 Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo Active CA2854271C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2011A000574 2011-11-02
IT000574A ITRM20110574A1 (it) 2011-11-02 2011-11-02 Preparato topico per indurre la pigmentazione cutanea e per il trattamento di discromie cutanee e vitiligine.
PCT/IT2012/000336 WO2013065078A2 (en) 2011-11-02 2012-11-02 Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo

Publications (2)

Publication Number Publication Date
CA2854271A1 CA2854271A1 (en) 2013-05-10
CA2854271C true CA2854271C (en) 2018-09-11

Family

ID=45315964

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2854271A Active CA2854271C (en) 2011-11-02 2012-11-02 Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo

Country Status (8)

Country Link
US (1) US9402906B2 (cg-RX-API-DMAC10.html)
EP (1) EP2773318B1 (cg-RX-API-DMAC10.html)
JP (1) JP6130846B2 (cg-RX-API-DMAC10.html)
CA (1) CA2854271C (cg-RX-API-DMAC10.html)
ES (1) ES2748866T3 (cg-RX-API-DMAC10.html)
IL (1) IL232419A0 (cg-RX-API-DMAC10.html)
IT (1) ITRM20110574A1 (cg-RX-API-DMAC10.html)
WO (1) WO2013065078A2 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800009384A1 (it) * 2018-10-11 2020-04-11 Cosmo Srl Peptide for cosmetic application
CN111282149B (zh) * 2019-08-08 2024-08-16 南京市江宁医院 一种白癜风纹饰治疗仪
IT202000005542A1 (it) * 2020-03-16 2021-09-16 Themis S R L Metodo cosmetico per il trattamento della pelle e per la ricrescita dei capelli
IT202000020287A1 (it) 2020-08-20 2022-02-20 Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi Peptide per applicazioni terapeutiche in campo dermatologico
WO2023072877A1 (en) * 2021-10-25 2023-05-04 Ellennbe Gmbh Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867179B1 (en) * 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US7196055B2 (en) * 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
US6063757A (en) * 1995-11-29 2000-05-16 Urso; Richard G. Wound treatment method with nerve growth factor
US6143723A (en) * 1996-05-20 2000-11-07 Ramaiah; Abburi Pigmentory agent

Also Published As

Publication number Publication date
WO2013065078A2 (en) 2013-05-10
CA2854271A1 (en) 2013-05-10
US20140242007A1 (en) 2014-08-28
JP6130846B2 (ja) 2017-05-17
EP2773318A2 (en) 2014-09-10
JP2014532694A (ja) 2014-12-08
ES2748866T3 (es) 2020-03-18
WO2013065078A3 (en) 2014-01-09
ITRM20110574A1 (it) 2013-05-03
US9402906B2 (en) 2016-08-02
IL232419A0 (en) 2014-06-30
EP2773318B1 (en) 2019-08-07

Similar Documents

Publication Publication Date Title
Gorouhi et al. Role of topical peptides in preventing or treating aged skin
CN101820849B (zh) 局部施用性化妆品或药物组合物
JP2024075684A (ja) 皮膚症状を改善するためのポリペプチドおよび方法
US9402906B2 (en) Topical preparation containing NGF for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo
US11071707B2 (en) Compositions for protecting skin comprising DNA repair enzymes and phycobiliprotein
CA2996126C (en) Compositions and methods for the treatment of photoaging and other skin conditions
KR102499651B1 (ko) 에리트로포이에틴-유래 분자를 함유하는 국소 적용을 위한 미용 제형
CA2716255C (en) Cosmetic and dermatological formulations of mntf peptides
KR100998920B1 (ko) 창상 치유용 피부 외용제 조성물
EP3434256B1 (en) Topical herbal compositions
US8304392B2 (en) Pharmaceutical and/or cosmetic composition containing an active principle activator of cytochrome C
AU2017425084B2 (en) Topical herbal compositions
JP2023539730A (ja) 皮膚科領域における治療用途のためのペプチド
TW201924656A (zh) 用於調節黑色素生成的方法及組成物
US20260021161A1 (en) Silk peptides topical formulations and methods of their use
Khalid et al. Anti-Aging topical peptides and proteins
CA3155594C (en) Topical anti-aging compositions containing a tetrapeptide
CA3070155C (en) Topical herbal composition obtained from bellis perennis and hieracium pisoella
US20220105024A1 (en) Intense Skin Hydration Systems and Methods
RU2469699C2 (ru) Косметическая композиция, содержащая ацетилгексапептид-6 и липосомы для местного применения

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160725

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241025

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241025